High-flow Nasal Oxygenation for Open Mouth

Status Terminated

Clinical Trial Summary

This study aims to evaluate the effect of high-flow nasal oxygenation on safe apnea time for children undergoing general anesthesia, with their mouth open.

Clinical Trial Description

Oxygenation via high-flow nasal cannula is gaining popularity in various clinical settings. It is known to increase apnea time for apneic patients including children. However, high-flow nasal cannula is known to be ineffective when the patient's mouth is kept open. When trying to intubate the patient during induction of anesthesia, the patient should be apneic with administration of neuromuscular blocking agent, and the mouth should be open for introduction of laryngoscope. We designed a prospective randomized controlled study to evaluate the effect of high-flow nasal oxygenation in the aforementioned setting for trying to intubate the patient. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04290728
Study type	Interventional
Source	Seoul National University Hospital
Contact
Status	Terminated
Phase	N/A
Start date	April 16, 2020
Completion date	February 19, 2021

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06063798` - Respiratory Effects of Flow-Controlled Ventilation and Jet Ventilation in Patients Undergoing Laryngotracheal Surgery	N/A
Not yet recruiting	`NCT05035069` - Efficacy and Safety of Ciprofol Compared to Propofol for Nonintubated General Anesthesia in Patients Undergoing TAVR	Phase 4
Completed	`NCT03861364` - Hemodynamics During Induction of General Anesthesia With High and Low Propofol Dose.	Phase 4
Completed	`NCT02711280` - The Effect of Anesthetics on Oxidative Stress and Apoptosis Status in Children	N/A
Completed	`NCT01199471` - Estimate the Behavior of Chinese Anesthesiologists Practicing General Anesthesia With Sevoflurane	N/A
Completed	`NCT00917033` - Tracheal Intubation of Morbidly Obese Patients. GlideScope Versus Direct Laryngoscopy	Phase 4
Completed	`NCT00391885` - Target-controlled Infusion of Propofol and Remifentanil During General Anaesthesia Guided by Entropy	Phase 4
Completed	`NCT00552617` - A Bridging Trial Comparing Sugammadex (Org 25969) at Reappearance of T2 in Japanese and Caucasian Participants. Part B: Caucasian Participants (P05971)	Phase 2
Completed	`NCT03705026` - Relationship Between Genetic Polymorphism and Postoperative Nausea and Vomiting in Chinese Han Population
Completed	`NCT00552929` - A Bridging Trial Comparing Sugammadex (Org 25969) at 1-2 Post-Tetanic Count (PTC) in Caucasian Participants. Part B (P05974)	Phase 2
Completed	`NCT00298831` - Use of Sugammadex at the End of Case in Routine Anesthesia (MK-8616-023)	Phase 3
Completed	`NCT00475215` - Safety and Efficacy of Sugammadex (Org 25969, MK-8616) in Participants With or Having a Past History of Pulmonary Disease (19.4.308) (P05932) (MK-8616-017)	Phase 3
Recruiting	`NCT03943745` - EEG Changes During Induction of Propofol Anesthesia
Completed	`NCT03697642` - Nasopharyngeal Airway Guide Nasogastric Tube Placement	N/A
Completed	`NCT04595591` - Observation of Propofol Titration at Different Speeds	N/A
Not yet recruiting	`NCT05841316` - The ED95 Dose of Sugammadex to Reverse Rocuronium-Induced Deep Neuromuscular Block Back to Shallow Neuromuscular Block
Completed	`NCT04532502` - Impact of Anesthetic Environment the Sex Ratio of the Children of Female Assistants
Completed	`NCT03330236` - EEG - Guided Anesthetic Care and Postoperative Delirium	N/A
Recruiting	`NCT06205212` - High-flow Nasal Oxygenation During Preoxygenation and Atelectasis	N/A
Completed	`NCT00379613` - Use of Sugammadex Administered at 5 Minutes After Administration of 1.2 mg/kg Esmeron® (19.4.205)(P05942)	Phase 2